In AD patients, dysfunction of the cholinergic system is one of the causes of cognitive and non-cognitive disorders where decreased activity of choline acetyltransferase (ChAT), an enzyme responsible for acetylcholine (ACh) synthesis, is noted [2]. This evidence concerns the gene CHAT and cognitive disorder.